Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
04/2012
04/12/2012CA2818215A1 Compositions and methods for treating ocular edema, neovascularization and related diseases
04/12/2012CA2816595A1 Combination therapy for the treatment of depression and other non-infectious diseases
04/12/2012CA2814084A1 Inhibitors of polo-like kinase
04/12/2012CA2813993A1 Method of preparation of antiviral compounds and useful intermediates thereof
04/12/2012CA2813901A1 Treatment of sialidase 4 (neu4) related diseases by inhibition of natural antisense transcript to neu4
04/12/2012CA2813748A1 Bepotastine compositions
04/12/2012CA2813738A1 Mutant smoothened and methods of using the same
04/12/2012CA2813736A1 New crystalline forms of the sodium salt of (4- {4- [5- ( 6 - trifluoromethyl - pyridin- 3 - ylamino ) - pyridin- 2 -yl] -phenyl} - cyclohexyl) -acetic acid
04/12/2012CA2813734A1 Use of rifalazil and analogues thereof to treat ocular disorders
04/12/2012CA2813719A1 Methods of use of small molecule modulators of hepatocyte growth factor (scatter factor) activity
04/12/2012CA2813704A1 Quinazoline compounds as sodium channel blockers
04/12/2012CA2813684A1 Novel combinations
04/12/2012CA2813639A1 Cyclic amide derivative
04/12/2012CA2813617A1 Antidiabetic enolic glucoside of phenylpyruvic acid
04/12/2012CA2813607A1 Substituted pyridazine carboxamide compounds
04/12/2012CA2813580A1 Substituted pyridazine carboxamide compounds as kinase inhibitor compounds
04/12/2012CA2813570A1 Porphyrin treatment of neurodegenerative diseases
04/12/2012CA2813563A1 Methods of making l-ornithine phenyl acetate
04/12/2012CA2813557A1 Method for activating helper t cell
04/12/2012CA2813437A1 Furo[3,2-d]pyrimidine compounds
04/12/2012CA2813388A1 New salt of a pyrimidin derivative
04/12/2012CA2813337A1 Salts and polymorphs of sulfamide ns3 inhibitors
04/12/2012CA2813329A1 Crystalline (r)-(e)-2-(4-(2-(5-(1-(3,5-dichloropyridin-4-yl)ethoxy)-1h-indazol-3-yl)vinyl)-1h-pyrazol-1-yl)ethanol
04/12/2012CA2813153A1 4-(methylaminophenoxy) pyrdin-3-yl-benzamide derivatives for treating cancer
04/12/2012CA2813003A1 Bortezomib formulations stabilised with boric acid
04/12/2012CA2812952A1 Methods and compositions for disease treatment using inhalation
04/12/2012CA2812926A1 Picropodophyllin monohydrate or polymorph a in cancer therapy
04/12/2012CA2812921A1 Picropodophyllin polymorphs b or c for use in cancer therapy
04/12/2012CA2812886A1 Coriolus versicolor extracts, methods of preparation and uses thereof
04/12/2012CA2812855A1 Hdac inhibitors to treat charcot-marie-tooth disease
04/12/2012CA2812786A1 Pharmaceutical combinations
04/12/2012CA2812608A1 Benzimidazole derivatives as pi3 kinase inhibitors
04/12/2012CA2812593A1 Alpha-ketoamide derivatives useful endothelial lipase inhibitors
04/12/2012CA2811799A1 Vitamin e formulations of sulfamide ns3 inhibitors
04/12/2012CA2811791A1 Novel substituted quinoline compounds as s-nitrosoglutathione reductase inhibitors
04/12/2012CA2811783A1 Combination treatment for rosacea
04/12/2012CA2811700A1 New treatments of hepatitis c virus infection
04/12/2012CA2811568A1 Novel composition
04/12/2012CA2807255A1 Co-crystals and salts of ccr3-inhibitors
04/11/2012EP2439279A1 Methods for genetic control of insect infestations in plants and compositions thereof
04/11/2012EP2439278A1 Methods for genetic control of insect infestations in plants and compositions thereof
04/11/2012EP2439207A1 Lactam Compounds Useful as Protein Kinase Inhibitors
04/11/2012EP2439206A1 Thiophene-carboxamides useful as inhibitors of protein kinases
04/11/2012EP2439205A1 Carboxamide compounds and their use as calpain inhibitors
04/11/2012EP2439204A1 Heterocyclic compound and hematopoietic stem cell amplifier
04/11/2012EP2439203A1 Arylsulfonylmethyl or arylsulfonamide substituted aromatic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor
04/11/2012EP2439202A1 Inhibitor compounds of 11-beta-hydroxysteroid dehydrogenase type 1
04/11/2012EP2439201A1 Compounds with combined SERT, 5-HT3 and 5-HT1A activity
04/11/2012EP2439200A1 Anthraquinone compounds and their uses
04/11/2012EP2439198A2 Novel method for preparing rosuvastatin, intermediate compounds useful for preparing same, and method for preparing same
04/11/2012EP2439197A1 Substituted benzimidazole derivatives as melanocortin 4 receptor antagonists
04/11/2012EP2439196A1 Diarylthiohydantoin compounds for use in a method for the treatment of a hyperproliferative disorder
04/11/2012EP2439195A1 Naphthalene carboxamide derivatives as inhibitors of protein kinase and histone deacetylase, preparation methods and uses thereof
04/11/2012EP2439194A1 Phenyl diamides and a pharmaceutical preparation comprising phenyl diamides
04/11/2012EP2439193A1 Derivatives of 5,6-bisaryl-2-pyridine-carboxamide, preparation and use thereof in therapeutics as antagonists of urotensin II receptors
04/11/2012EP2438923A1 Composition for preventing or treating obesity-related diseases mediated by the activation of ampk and including 2,5-bis-aryl-3,4-dimethyltetrahydrofuran lignans as active ingredients
04/11/2012EP2438921A1 23-O-Acetylshengmanol-3-O-beta-D-xylopyranoside and its medical use
04/11/2012EP2438920A1 Controlled-Release Formulations of Quetiapine
04/11/2012EP2438919A1 Compositions comprising famotidine and ibuprofen as well as compositions comprising 25 mg to 28 mg famotidine
04/11/2012EP2438918A1 Benzimidazole-derived compounds used as markers in the case of neurodegenerative diseases
04/11/2012EP2438917A1 Transdermal preparation
04/11/2012EP2438916A1 Neurite elongation agent, memory-improving agent and anti-alzheimer agent comprising 4'-demethylnobiletin or 4'-demethyltangeretin as active ingredient, and process for production of the compound
04/11/2012EP2438915A1 Improvement of arginase levels/activity
04/11/2012EP2438914A1 Pharmaceutical composition comprising Z-butylidenephthalide for treating brain cancer or reducing temozolomide-resistance of brain cancer cells and use
04/11/2012EP2438913A1 A non-selective cation channel in neural cells and compounds that block the channel for use in treating brain swelling
04/11/2012EP2438912A2 Plaster containing fentanyl
04/11/2012EP2438911A1 Pharmaceuticals compositions comprising sulphonylurea-class insulin secretagogue and polyethylene glycol castor oil
04/11/2012EP2438907A2 Teeth mouthwash and mouthwash concentrates
04/11/2012EP2438191A1 Lysine-specific demethylase 1 (lsd1) is a biomarker for breast cancer
04/11/2012EP2438169A1 Nucleic acid modulators of glycoprotein vi
04/11/2012EP2438168A2 Polynucleotides for multivalent rna interference, compositions and methods of use thereof
04/11/2012EP2438079A2 Nucleic acid delivery compositions and methods of use thereof
04/11/2012EP2438076A1 Targetted drug delivery to the bone
04/11/2012EP2438070A1 Glycine b antagonists
04/11/2012EP2438069A1 Substituted [1,2,4]triazolo[1,5-a]pyrimidines and their use as potassium channel modulators
04/11/2012EP2438068A1 Substituted 6-(2-hydroxybenzylamino)purine derivatives, their use as medicaments and compositions containing these derivatives
04/11/2012EP2438067A1 New compounds
04/11/2012EP2438066A2 PREPARATION AND USES OF 1,2,4-TRIAZOLO [1,5a]PYRIDINE DERIVATIVES
04/11/2012EP2438064A1 1H-IMIDAZO[4,5-c]QUINOLINONE DERIVATIVES
04/11/2012EP2438063A1 1h-imidazo[4,5-c]quinolinone compounds, useful for the treatment of proliferative diseases
04/11/2012EP2438060A1 Active metabolite of a thrombin receptor antagonist
04/11/2012EP2438059A1 Aminopyrrolidinone derivatives and uses thereof
04/11/2012EP2438058A2 Crystalline forms of 6- ( 1h- imidazol- 1-yl) -2-phenylquinazoline and salts thereof
04/11/2012EP2438056A2 Amino pyrimidine anticancer compounds
04/11/2012EP2438055A1 Dihydroindole and tetrahydroisoquinoline derivatives useful as potassium channel inhibitors
04/11/2012EP2438052A1 Azole derivatives as wtn pathway inhibitors
04/11/2012EP2438051A1 L- ( piperidin-4-yl) -pyrazole derivatives as gpr 119 modulators
04/11/2012EP2438050A1 Novel derivatives of aryl-{4-halogeno-4-[aminomethyl]-piperidin-1-yl}-methanone, their method of preparation and their use as medicinal products
04/11/2012EP2438049A1 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
04/11/2012EP2438048A2 Polycyclic antagonists of lysophosphatidic acid receptors
04/11/2012EP2438047A2 Antagonism of human formyl peptide receptor for treatment of disease
04/11/2012EP2438046A2 O-glcnac transferase inhibitors and uses thereof
04/11/2012EP2438045A2 Crystalline phases of 2'-{[2-(4-methoxy-phenyl)-acetylamino]-methyl}-biphenyl-2-carboxylic acid (2-pyridin-3-yl-ethyl)-amide
04/11/2012EP2438043A1 Carbamate and urea inhibitors of 11beta-hydroxysteroid dehydrogenase 1
04/11/2012EP2438041A1 Pyrazine carboxamide orexin receptor antagonists
04/11/2012EP2438037A1 Glycine b antagonists
04/11/2012EP2437782A2 Stabilised composition comprising at least one adrenergic compound
04/11/2012EP2437781A2 Stabilised composition comprising at least one adrenergic compound
04/11/2012EP2437774A1 Diagnosis of restenosis in patients undergoing percutaneous coronary intervention
04/11/2012EP2437771A2 Compositions and methods modulating mg29 for the treatment of diabetes
1 ... 1279 1280 1281 1282 1283 1284 1285 1286 1287 1288 1289 1290 1291 1292 1293 1294 1295 1296 1297 1298 1299 ... 7860